Skip to search formSkip to main contentSkip to account menu

SB-480848

Known as: 480848, GSK480848, SB 480848 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Pyrimidinonesdarapladib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
PII‐3
Review
2004
Review
2004
SB-480848. GlaxoSmithKline.
SB-480848 is a reversible lipoprotein-associated phospholipase A2 inhibitor under development by GlaxoSmithKline for the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)